87
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic Clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan

, , , , , , , , & show all
Pages 1197-1203 | Published online: 15 Aug 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ching-Chi Lee, Jen-Chieh Lee, Chun-Wei Chiu, Pei-Jane Tsai, Wen-Chien Ko & Yuan-Pin Hung. (2022) Neutrophil Ratio of White Blood Cells as a Prognostic Predictor of Clostridioides difficile Infection. Journal of Inflammation Research 15, pages 1943-1951.
Read now
Jingpeng Yang & Hong Yang. (2019) Non-antibiotic therapy for Clostridioides difficile infection: a review. Critical Reviews in Clinical Laboratory Sciences 56:7, pages 493-509.
Read now

Articles from other publishers (19)

Chin-Shiang Tsai, Po-Liang Lu, Min-Chi Lu, Tai-Chin Hsieh, Wei-Ting Chen, Jann-Tay Wang & Wen-Chien Ko. (2024) Ribotypes and antimicrobial susceptibility profiles of clinical Clostridioides difficile isolates: A multicenter, laboratory-based surveillance in Taiwan, 2019–2021. Journal of Microbiology, Immunology and Infection 57:2, pages 320-327.
Crossref
Stefano Di Bella, Gianfranco Sanson, Jacopo Monticelli, Verena Zerbato, Luigi Principe, Mauro Giuffrè, Giuseppe Pipitone & Roberto Luzzati. (2024) Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options . Clinical Microbiology Reviews.
Crossref
Jieun Kim, Bongyoung Kim & Hyunjoo Pai. (2023) Diversity of binary toxin positive Clostridioides difficile in Korea. Scientific Reports 13:1.
Crossref
Jen-Chieh Lee, Ching-Chi Lee, Chun-Wei Chiu, Pei-Jane Tsai, Po-Ren Hsueh, Yuan-Ti Lee, Yuan-Pin Hung & Wen-Chien Ko. (2022) Reappraisal of the clinical role of metronidazole therapy for Clostridioides difficile infection in Taiwan: A multicenter prospective study. Journal of the Formosan Medical Association 121:12, pages 2608-2616.
Crossref
Chin-Shiang Tsai, Ya-Lien Cheng, Jung-Sheng Chen, Pei-Jane Tsai, Bo-Yang Tsai, Bing-Mu Hsu & I-Hsiu Huang. (2022) Hypervirulent Clostridioides difficile RT078 lineage isolates from the river: A potential reservoir for environmental transmission. Journal of Microbiology, Immunology and Infection 55:5, pages 977-981.
Crossref
Bo-Yang Tsai, Chun-Chih Chien, Shu-Huan Huang, Jun-Yuan Zheng, Chih-Yu Hsu, Yau-Sheng Tsai, Yuan-Pin Hung, Wen-Chien Ko & Pei-Jane Tsai. (2022) The emergence of Clostridioides difficile PCR ribotype 127 at a hospital in northeastern Taiwan. Journal of Microbiology, Immunology and Infection 55:5, pages 896-909.
Crossref
Pei-Chang Lee, Tien-En Chang, Yen-Po Wang, Kuei-Chuan Lee, Yi-Tsung Lin, Jen-Jie Chiou, Chi-Wei Huang, Ueng-Cheng Yang, Fen-Yau Li, Hui-Chun Huang, Chun-Ying Wu, Yi-Hsiang Huang & Ming-Chih Hou. (2022) Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection. Journal of the Formosan Medical Association 121:9, pages 1636-1646.
Crossref
Deiziane V. S. Costa, Natalie V. S. Pham, Rachel A. Hays, David T. Bolick, Sophia M. Goldbeck, Melinda D. Poulter, Sook C. Hoang, Jae H. Shin, Martin Wu & Cirle A. Warren. (2022) Influence of Binary Toxin Gene Detection and Decreased Susceptibility to Antibiotics among Clostridioides difficile Strains on Disease Severity: a Single-Center Study. Antimicrobial Agents and Chemotherapy 66:8.
Crossref
Adrián Martínez-Meléndez, Flora Cruz-López, Rayo Morfin-Otero, Héctor J. Maldonado-Garza & Elvira Garza-González. (2022) An Update on Clostridioides difficile Binary Toxin. Toxins 14:5, pages 305.
Crossref
Marie Brajerova, Jaroslava Zikova & Marcela Krutova. (2022) Clostridioides difficile epidemiology in the Middle and the Far East. Anaerobe 74, pages 102542.
Crossref
Bo-Yang Tsai, Yi-Hsin Lai, Chun-Wei Chiu, Chih-Yu Hsu, Yi-Hsuan Chen, Yueh-Lin Chen, Pei-Jane Tsai, Yuan-Pin Hung & Wen-Chien Ko. (2022) Effect of Doxycycline in Decreasing the Severity of Clostridioides difficile Infection in Mice. Antibiotics 11:1, pages 116.
Crossref
Yuan-Pin Hung, Chin-Shiang Tsai, Bo-Yang Tsai, Pei-Jane Tsai, Yuan-Ti Lee, Jen-Chieh Lee, Hsiu-Chuan Liu, Po-Ren Hsueh, Ching-Chi Lee & Wen-Chien Ko. (2021) Clostridioides difficile infection in patients with hematological malignancy: A multicenter study in Taiwan. Journal of Microbiology, Immunology and Infection 54:6, pages 1101-1110.
Crossref
Jen-Chieh Lee, Yuan-Pin Hung, Bo-Yang Tsai, Pei-Jane Tsai & Wen-Chien Ko. (2021) Severe Clostridium difficile infections in intensive care units: Diverse clinical presentations. Journal of Microbiology, Immunology and Infection 54:6, pages 1111-1117.
Crossref
Mohammad Sholeh, Marcela Krutova, Mehdi Forouzesh, Sergey Mironov, Nourkhoda Sadeghifard, Leila Molaeipour, Abbas Maleki & Ebrahim Kouhsari. (2020) Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis. Antimicrobial Resistance & Infection Control 9:1.
Crossref
Adrián Martínez-Meléndez, Rayo Morfin-Otero, Licet Villarreal-Treviño, Simon D. Baines, Adrián Camacho-Ortíz & Elvira Garza-González. (2020) Molecular epidemiology of predominant and emerging Clostridioides difficile ribotypes. Journal of Microbiological Methods 175, pages 105974.
Crossref
Kuan-Sheng Wu, Ling-Shan Syue, Aristine Cheng, Ting-Yu Yen, Hsien-Meng Chen, Yu-Hsin Chiu, Yu-Lung Hsu, Chun-Hsiang Chiu, Ting-Yi Su, Wan-Lin Tsai, Wei-Yu Chen, Chung-Hao Huang, Huei-Min Hung, Ling-Ju Huang, Hong-Jie Kuo, Pei-Chin Lin, Ching-Hsiang Yang, Pi-Lien Hong, Susan Shin-Jung Lee, Yao-Shen Chen, Yung-Ching Liu & Li-Ming Huang. (2020) Recommendations and guidelines for the treatment of Clostridioides difficile infection in Taiwan. Journal of Microbiology, Immunology and Infection 53:2, pages 191-208.
Crossref
D. Lachowicz, H. Pituch, D. Wultańska, E. Kuijper & P. Obuch-Woszczatyński. (2020) Surveillance of antimicrobial susceptibilities reveals high proportions of multidrug resistance in toxigenic Clostridium difficile strains in different areas of Poland. Anaerobe 62, pages 102167.
Crossref
Jerry W. Simecka, Kimberly G. Fulda, Mark Pulse, Joon-hak Lee, John Vitucci, Phung Nguyen, Patricia Taylor, Frank Filipetto, Anna M. Espinoza & Sushma Sharma. (2019) Primary care clinics can be a source of exposure to virulent Clostridium (now Clostridioides) difficile: An environmental screening study of hospitals and clinics in Dallas-Fort Worth region. PLOS ONE 14:8, pages e0220646.
Crossref
Deirdre Collins & Thomas Riley. (2018) Clostridium difficile in Asia: Opportunities for One Health Management. Tropical Medicine and Infectious Disease 4:1, pages 7.
Crossref